2. Long-term monopoly: Patent protection should have a reasonable period to encourage pharmaceutical companies to innovate, but it should also avoid long-term monopoly to make drug prices too high or limit patients' choices.
3. Restrict the popularization and access to medicines: Patent protection should not restrict patients from obtaining necessary medicines and treatments, especially in emergency situations.